Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology Drug Development

NEXT STORY
Vaxart, Inc. to Present at the H.C. Wainwright Virtual Fireside Chat Series
PREV STORY
Global Infection Control Market (2018 to 2027) – Increasing Use of E-Beam Sterilization Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CHF Solutions to Attend Southwest Nephrology Conference and Cardio Renal Metabolic Conference

EDEN PRAIRIE, Minn., Oct. 03, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) ...

author_avatar
NASDAQ Market News

Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation

LYSAKER, Norway, Feb. 25, 2016 (GLOBE NEWSWIRE) -- Targovax ASA (Targovax) will release its ...

author_avatar
NASDAQ Market News

Fate Therapeutics Announces Preclinical Data from Immuno-Regulatory CD34+ Cell Therapy for Autoimmune Diseases

One-time Administration of Programmed Cells Demonstrates Durable Disease Correction in Type 1 Diabetes Mouse Model ...

author_avatar
NASDAQ Market News